查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1941468

益智藥市場規模、佔有率和趨勢分析報告：按劑型、分銷管道、地區和細分市場預測，2026-2033年

Nootropics Market Size, Share & Trends Analysis Report By Form, By Distribution Channel, By Region, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 80 Pages | 商品交期: 2-10個工作天內

價格

益智藥市場概況

預計到 2025 年，全球益智藥市場規模將達到 54.5 億美元，到 2033 年將達到 114.8 億美元。

預計從 2026 年到 2033 年，該行業將以 9.1% 的複合年成長率成長。由於該領域的技術進步和現代化，預計該行業在預測期內將經歷快速擴張。

預計在預測期內，消費者在各類醫療保健和健康產品上的支出不斷成長將推動該行業的成長。此外，這些產品的性價比和易得性預計也將進一步提升消費者對其的需求。

人們對整體健康的日益關注，帶動了對天然植物性促智藥的需求成長。這些化合物因其植物來源，符合自然、永續和符合倫理的健康理念而備受推崇。秉承整體健康理念，它們被視為提升認知能力、促進身心平衡的有效途徑。消費者對健康和保健日益成長的興趣，推動了這個市場的快速成長。隨著越來越多的人進入大學深造，以及低失業率導致勞動市場對高素質人才的需求，求職者們正在尋求自然的方式來提升自身競爭力，並提高工作表現。

未來六年，健康消費者對認知能力提升的需求日益成長，他們希望藉此獲得學業和職業上的優勢，預計這將推動益智藥的需求成長。此外，運動員、運動專業人士和自我提升消費者對這類產品的接受度不斷提高，預計也將在預測期內對市場產生正面影響。

由於人口老化以及包括失智症在內的各種腦部疾病和關節炎等問題的發病率不斷上升，人們對益智藥的需求日益成長。此外，這些產品也用於治療其他認知障礙和與老齡化相關的疾病，例如過動症和帕金森氏症。憂鬱症和其他情緒障礙影響著全球眾多消費者。因此，預計未來六年，對情緒增強劑的需求成長也將推動該產業的成長。

為了滿足日益成長的益智藥需求，製造商們正致力於研發、推出新產品、品管、開發純素和植物來源產品，以及面向不同細分市場的特色產品。例如，2025年8月，前身為Impact Coffee的Unconform推出了一系列添加了益智成分的冷萃即飲咖啡。這些咖啡旨在改善思維清晰度、延長認知壽命，並促進消化器官系統和免疫健康，且不會產生典型的咖啡因副作用。 250毫升罐裝咖啡共有三種口味：馥芮白（睡茄、銀杏葉萃取物和維生素B12）、鹹焦糖拿鐵（添加菊糖和薑黃）以及摩卡（添加菸鹼酸和生物素）。每罐售價2.50英鎊。此外，Unconform還提供無味的“智慧棒”，用於增強免疫力、提升思維清晰度、改善腸道健康和美容功效。一盒10袋售價7.99英鎊（約1300日圓）。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章 益智藥市場變數、趨勢與範圍

  • 市場譜系展望
  • 產業價值鏈分析
    • 銷售/零售通路分析
    • 利潤率分析
  • 市場動態
  • 產業分析—波特五力分析
  • 打入市場策略

第4章消費行為分析

  • 人口統計分析
  • 消費者趨勢和偏好
  • 影響購買決策的因素
  • 消費品採納
  • 主要觀察結果和發現

第5章 益智藥市場：依劑型分類的估算與趨勢分析

  • 按類型分類的變化分析和市場佔有率（2025 年和 2033 年）
  • 膠囊/片劑
  • 粉末
  • 飲料
  • 其他

第6章 益智藥市場：按分銷管道分類的估算與趨勢分析

  • 2025年及2033年各通路的變化及市佔率分析
  • 離線
  • 線上

第7章 益智藥市場：區域估算與趨勢分析

  • 區域趨勢分析及市場佔有率（2025年及2033年）
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 法國
    • 義大利
    • 西班牙
  • 亞太地區
    • 中國
    • 印度
    • 日本
    • 韓國
    • 澳洲和紐西蘭
  • 拉丁美洲
    • 巴西
  • 中東和非洲
    • 阿拉伯聯合大公國

第8章 競爭分析

  • 對主要市場參與企業近期趨勢和影響的分析
  • 公司分類
  • 參與企業概況
  • 財務業績
  • 產品基準測試
  • 企業市場占有率分析（2025 年，%）
  • 公司熱力圖分析
  • 策略規劃
  • 本節分析的主要企業包括：
    • Onnit Labs, Inc.
    • Reckitt Benckiser Group PLC
    • Mental Mojo, LLC
    • NooCube
    • Mind Lab Pro（Performance Lab Group Ltd）
    • TruBrain
    • Neu Mind, LLC
    • Nooflux LLC
    • Zhou Nutrition
    • Kimera Koffee
Product Code: GVR-4-68039-914-3

Nootropics Market Summary

The global nootropics market size was valued at USD 5.45 billion in 2025 and is anticipated to reach USD 11.48 billion by 2033, growing at a CAGR of 9.1% from 2026 to 2033. The industry is expected to expand at a rapid pace over the forecast period on account of technological advancements as well as modernization in the field.

Rising consumer spending on various healthcare as well as wellness products is expected to fuel industry growth over the forecast period. In addition, cost-effectiveness as well as easy accessibility to these products are further expected to boost product needs among consumers.

The demand for natural and plant-based nootropics has increased with growing interest in holistic health. These compounds are recommended because they are sourced from plants and are in line with natural, sustainable, and ethical wellness practices. In keeping with the holistic health concept, they are viewed as a means of improving cognitive performance while encouraging balance between the mind and body. This market surge is a result of the rising consumer focus on health and wellness. With the increasing number of students attending college as well as a workforce that demands better qualifications due to the low unemployment rate, prospective candidates have been seeking natural ways to gain a competitive advantage and improve their performance.

The rising trend of cognitive enhancement among healthy consumers for academic and professional advantage is expected to fuel the need for nootropics over the next six years. In addition, the growing use of the product among athletes and sports professionals, as well as among consumers for personal improvement, will have a positive impact on the market over the forecast period.

The growing geriatric population, coupled with the rising occurrence of various brain-related diseases, including dementia and other issues such as arthritis, has increased the need for nootropics. Moreover, these products are employed for the treatment of other cognitive and age-related disorders, including hyperactivity, as well as Parkinson's disease. Numerous consumers across the globe have been undergoing depression as well as other mood and emotional disorders. Thus, rising demand for mood enhancers is also expected to stimulate industry growth over the next six years.

Manufacturers are responding to the rising demand for nootropics by focusing on research and development, as well as new product launches, quality control, vegan and plant-based options, and specialized products for various niches. For instance, in August 2025, Unconform, formerly Impact Coffee, launched a nootropic-enhanced cold brew RTD coffee line designed to improve mental clarity, cognitive longevity, digestive, and immune health without typical caffeine side effects. The 250ml cans come in three flavors: Flat White (with Ashwagandha, Ginkgo Biloba & Vitamin B12), Salted Caramel Latte (with Inulin and Turmeric), and Mocha (with Niacin & Biotin), priced at £2.50 each. Additionally, Unconform offers Smart Sticks-neutral-flavored sachets that boost immunity, mental clarity, gut health, or beauty, priced at £7.99 for a box of 10 sachets.

Global Nootropics Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segment from 2021 to 2033. For this study, Grand View Research has segmented the global nootropics market report on the basis of form, distribution channel, and region:

  • Form Outlook (Revenue, USD Million, 2021 - 2033)
  • Capsules/Tablets
  • Powder
  • Drinks
  • Others
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Offline
  • Online
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia & New Zealand
    • South Korea
  • Central & South America
    • Brazil
  • Middle East & Africa
    • UAE

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Market Definition
  • 1.3. Information Procurement
    • 1.3.1. Purchased Database
    • 1.3.2. GVR's Internal Database
    • 1.3.3. Secondary Products & Third-Party Perspectives
    • 1.3.4. Primary Research
  • 1.4. Information Analysis
    • 1.4.1. Data Analysis Models
  • 1.5. Market Formulation & Data Visualization
  • 1.6. Data Validation & Publishing

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Product Outlook
  • 2.3. Distribution Channel Outlook
  • 2.4. Regional Outlook

Chapter 3. Nootropics Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Industry Value Chain Analysis
    • 3.2.1. Sales/Retail Channel Analysis
    • 3.2.2. Profit Margin Analysis
  • 3.3. Market Dynamics
    • 3.3.1. Market Driver Analysis
    • 3.3.2. Market Restraint Analysis
    • 3.3.3. Market Opportunities
    • 3.3.4. Market Challenges
  • 3.4. Industry Analysis - Porter's Five Forces Analysis
  • 3.5. Market Entry Strategies

Chapter 4. Consumer Behavior Analysis

  • 4.1. Demographics Analysis
  • 4.2. Consumer Trends and Preferences
  • 4.3. Factors Affecting Buying Decision
  • 4.4. Consumer Product Adoption
  • 4.5. Key Observations & Findings

Chapter 5. Nootropics Market: Form Estimates & Trend Analysis

  • 5.1. Form Movement Analysis & Market Share, 2025 & 2033
  • 5.2. Capsules/Tablets
    • 5.2.1. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 5.3. Powder
    • 5.3.1. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 5.4. Drinks
    • 5.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 5.5. Others
    • 5.5.1. Market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 6. Nootropics Market: Distribution Channel Range Estimates & Trend Analysis

  • 6.1. Distribution Channel Movement Analysis & Market Share, 2025 & 2033
  • 6.2. Offline
    • 6.2.1. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 6.3. Online
    • 6.3.1. Market estimates and forecast, 2021 - 2033 (USD Million)

Chapter 7. Nootropics Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Movement Analysis & Market Share, 2025 & 2033
  • 7.2. North America
    • 7.2.1. Market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.2.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
    • 7.2.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
    • 7.2.4. U.S.
      • 7.2.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
      • 7.2.4.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
      • 7.2.4.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
    • 7.2.5. Canada
      • 7.2.5.1. Market estimates and forecast, 2021 - 2033 (USD Million)
      • 7.2.5.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
      • 7.2.5.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
    • 7.2.6. Mexico
      • 7.2.6.1. Market estimates and forecast, 2021 - 2033 (USD Million)
      • 7.2.6.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
      • 7.2.6.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
  • 7.3. Europe
    • 7.3.1. Market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.3.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
    • 7.3.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
    • 7.3.4. Germany
      • 7.3.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
      • 7.3.4.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
      • 7.3.4.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
    • 7.3.5. U.K.
      • 7.3.5.1. Market estimates and forecast, 2021 - 2033 (USD Million)
      • 7.3.5.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
      • 7.3.5.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
    • 7.3.6. France
      • 7.3.6.1. Market estimates and forecast, 2021 - 2033 (USD Million)
      • 7.3.6.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
      • 7.3.6.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
    • 7.3.7. Italy
      • 7.3.7.1. Market estimates and forecast, 2021 - 2033 (USD Million)
      • 7.3.7.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
      • 7.3.7.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
    • 7.3.8. Spain
      • 7.3.8.1. Market estimates and forecast, 2021 - 2033 (USD Million)
      • 7.3.8.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
      • 7.3.8.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.4.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
    • 7.4.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
    • 7.4.4. China
      • 7.4.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
      • 7.4.4.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
      • 7.4.4.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
    • 7.4.5. India
      • 7.4.5.1. Market estimates and forecast, 2021 - 2033 (USD Million)
      • 7.4.5.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
      • 7.4.5.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
    • 7.4.6. Japan
      • 7.4.6.1. Market estimates and forecast, 2021 - 2033 (USD Million)
      • 7.4.6.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
      • 7.4.6.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
    • 7.4.7. South Korea
      • 7.4.7.1. Market estimates and forecast, 2021 - 2033 (USD Million)
      • 7.4.7.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
      • 7.4.7.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
    • 7.4.8. Australia & New Zealand
      • 7.4.8.1. Market estimates and forecast, 2021 - 2033 (USD Million)
      • 7.4.8.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
      • 7.4.8.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
  • 7.5. Central & South America
    • 7.5.1. Market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.5.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
    • 7.5.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
    • 7.5.4. Brazil
      • 7.5.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
      • 7.5.4.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
      • 7.5.4.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
  • 7.6. Middle East & Africa
    • 7.6.1. Market estimates and forecast, 2021 - 2033 (USD Million)
    • 7.6.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
    • 7.6.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)
    • 7.6.4. UAE
      • 7.6.4.1. Market estimates and forecast, 2021 - 2033 (USD Million)
      • 7.6.4.2. Market estimates and forecast, by form, 2021 - 2033 (USD Million)
      • 7.6.4.3. Market estimates and forecast, by distribution channel, 2021 - 2033 (USD Million)

Chapter 8. Competitive Analysis

  • 8.1. Recent developments & impact analysis, by key market participants
  • 8.2. Company Categorization
  • 8.3. Participant's Overview
  • 8.4. Financial Performance
  • 8.5. Product Benchmarking
  • 8.6. Company Market Share Analysis, 2025 (%)
  • 8.7. Company Heat Map Analysis
  • 8.8. Strategy Mapping
  • 8.9. List of key companies analyzed in this section include:
    • 8.9.1. Onnit Labs, Inc.
      • 8.9.1.1. Company Overview
      • 8.9.1.2. Financial Performance
      • 8.9.1.3. Product Benchmarking
      • 8.9.1.4. Strategic Initiatives
    • 8.9.2. Reckitt Benckiser Group PLC
      • 8.9.2.1. Company Overview
      • 8.9.2.2. Financial Performance
      • 8.9.2.3. Product Benchmarking
      • 8.9.2.4. Strategic Initiatives
    • 8.9.3. Mental Mojo, LLC
      • 8.9.3.1. Company Overview
      • 8.9.3.2. Financial Performance
      • 8.9.3.3. Product Benchmarking
      • 8.9.3.4. Strategic Initiatives
    • 8.9.4. NooCube
      • 8.9.4.1. Company Overview
      • 8.9.4.2. Financial Performance
      • 8.9.4.3. Product Benchmarking
      • 8.9.4.4. Strategic Initiatives
    • 8.9.5. Mind Lab Pro (Performance Lab Group Ltd)
      • 8.9.5.1. Company Overview
      • 8.9.5.2. Financial Performance
      • 8.9.5.3. Product Benchmarking
      • 8.9.5.4. Strategic Initiatives
    • 8.9.6. TruBrain
      • 8.9.6.1. Company Overview
      • 8.9.6.2. Financial Performance
      • 8.9.6.3. Product Benchmarking
      • 8.9.6.4. Strategic Initiatives
    • 8.9.7. Neu Mind, LLC
      • 8.9.7.1. Company Overview
      • 8.9.7.2. Financial Performance
      • 8.9.7.3. Product Benchmarking
      • 8.9.7.4. Strategic Initiatives
    • 8.9.8. Nooflux LLC
      • 8.9.8.1. Company Overview
      • 8.9.8.2. Financial Performance
      • 8.9.8.3. Product Benchmarking
      • 8.9.8.4. Strategic Initiatives
    • 8.9.9. Zhou Nutrition
      • 8.9.9.1. Company Overview
      • 8.9.9.2. Financial Performance
      • 8.9.9.3. Product Benchmarking
      • 8.9.9.4. Strategic Initiatives
    • 8.9.10. Kimera Koffee
      • 8.9.10.1. Company Overview
      • 8.9.10.2. Financial Performance
      • 8.9.10.3. Product Benchmarking
      • 8.9.10.4. Strategic Initiatives

List of Tables

  • 1. Nootropics Market - Key market driver analysis
  • 2. Nootropics Market - Key market restraint analysis
  • 3. Capsules/tablets nootropics market estimates and forecast, 2021 - 2033 (USD Million)
  • 4. Nootropics powder market estimates and forecast, 2021 - 2033 (USD Million)
  • 5. Nootropics drinks market estimates and forecast, 2021 - 2033 (USD Million)
  • 6. Other nootropics market estimates and forecast, 2021 - 2033 (USD Million)
  • 7. Nootropics market estimates and forecast, through online, 2021 - 2033 (USD Million)
  • 8. Nootropics market estimates and forecast, through offline, 2021 - 2033 (USD Million)
  • 9. North America garage organization & storage market estimates and forecast, 2021 - 2033 (USD Million)
  • 10. North America nootropics market, by form, 2021 - 2033 (USD Million)
  • 11. North America nootropics market, by distribution channel, 2021 - 2033 (USD Million)
  • 12. U.S. nootropics market estimates and forecast, 2021 - 2033 (USD Million)
  • 13. U.S. nootropics market, by form, 2021 - 2033 (USD Million)
  • 14. U.S. garage organization & storage market, by distribution channel, 2021 - 2033 (USD Million)
  • 15. Canada nootropics market estimates and forecast, 2021 - 2033 (USD Million)
  • 16. Canada nootropics market, by form, 2021 - 2033 (USD Million)
  • 17. Canada nootropics market, by distribution channel, 2021 - 2033 (USD Million)
  • 18. Mexico nootropics market estimates and forecast, 2021 - 2033 (USD Million)
  • 19. Mexico nootropics market, by form, 2021 - 2033 (USD Million)
  • 20. Mexico nootropics market, by distribution channel, 2021 - 2033 (USD Million)
  • 21. Europe nootropics market estimates and forecast, 2021 - 2033 (USD Million)
  • 22. Europe nootropics market, by form, 2021 - 2033 (USD Million)
  • 23. Europe nootropics market, by distribution channel, 2021 - 2033 (USD Million)
  • 24. U.K. nootropics market estimates and forecast, 2021 - 2033 (USD Million)
  • 25. U.K. nootropics market, by form, 2021 - 2033 (USD Million)
  • 26. U.K. nootropics market, by distribution channel, 2021 - 2033 (USD Million)
  • 27. Germany nootropics market estimates and forecast, 2021 - 2033 (USD Million)
  • 28. Germany nootropics market, by form, 2021 - 2033 (USD Million)
  • 29. Germany nootropics market, by application, 2021 - 2033 (USD Million)
  • 30. France nootropics market estimates and forecast, 2021 - 2033 (USD Million)
  • 31. France nootropics market, by form, 2021 - 2033 (USD Million)
  • 32. France garage organization & storage market, by distribution channel, 2021 - 2033 (USD Million)
  • 33. Italy nootropics market estimates and forecast, 2021 - 2033 (USD Million)
  • 34. Italy nootropics market, by form, 2021 - 2033 (USD Million)
  • 35. Italy nootropics market, by distribution channel, 2021 - 2033 (USD Million)
  • 36. Spain nootropics market estimates and forecast, 2021 - 2033 (USD Million)
  • 37. Spain nootropics market, by form, 2021 - 2033 (USD Million)
  • 38. Spain nootropics market, by distribution channel, 2021 - 2033 (USD Million)
  • 39. Asia Pacific nootropics market estimates and forecast, 2021 - 2033 (USD Million)
  • 40. Asia Pacific nootropics market, by form, 2021 - 2033 (USD Million)
  • 41. Asia Pacific nootropics market, by distribution channel, 2021 - 2033 (USD Million)
  • 42. India nootropics market estimates and forecast, 2021 - 2033 (USD Million)
  • 43. India nootropics market, by form, 2021 - 2033 (USD Million)
  • 44. India nootropics market, by distribution channel, 2021 - 2033 (USD Million)
  • 45. China nootropics market estimates and forecast, 2021 - 2033 (USD Million)
  • 46. China nootropics market, by form, 2021 - 2033 (USD Million)
  • 47. China nootropics market, by distribution channel, 2021 - 2033 (USD Million)
  • 48. Japan nootropics market estimates and forecast, 2021 - 2033 (USD Million)
  • 49. Japan nootropics market, by form, 2021 - 2033 (USD Million)
  • 50. Japan nootropics market, by distribution channel, 2021 - 2033 (USD Million)
  • 51. South Korea nootropics market estimates and forecast, 2021 - 2033 (USD Million)
  • 52. South Korea nootropics market, by form, 2021 - 2033 (USD Million)
  • 53. South Korea nootropics market, by distribution channel, 2021 - 2033 (USD Million)
  • 54. Australia & New Zealand nootropics market estimates and forecast, 2021 - 2033 (USD Million)
  • 55. Australia & New Zealand nootropics market, by form, 2021 - 2033 (USD Million)
  • 56. Australia & New Zealand nootropics market, by distribution channel, 2021 - 2033 (USD Million)
  • 57. Central & South America nootropics market estimates and forecast, 2021 - 2033 (USD Million)
  • 58. Central & South America nootropics market, by form, 2021 - 2033 (USD Million)
  • 59. Central & South America nootropics market, by distribution channel, 2021 - 2033 (USD Million)
  • 60. Brazil nootropics market estimates and forecast, 2021 - 2033 (USD Million)
  • 61. Brazil nootropics market, by form, 2021 - 2033 (USD Million)
  • 62. Brazil nootropics market, by distribution channel, 2021 - 2033 (USD Million)
  • 63. Middle East & Africa nootropics market estimates and forecast, 2021 - 2033 (USD Million)
  • 64. Middle East & Africa nootropics market, by form, 2021 - 2033 (USD Million)
  • 65. Middle East & Africa nootropics market, by distribution channel, 2021 - 2033 (USD Million)
  • 66. UAE nootropics market estimates and forecast, 2021 - 2033 (USD Million)
  • 67. UAE nootropics market, by form, 2021 - 2033 (USD Million)
  • 68. UAE nootropics market, by distribution channel, 2021 - 2033 (USD Million)
  • 69. Vendor Landscape

List of Figures

  • 1. Nootropics Market Snapshot
  • 2. Nootropics Market segmentation & scope
  • 3. Nootropics Market penetration & growth prospect mapping
  • 4. Nootropics Market value chain analysis
  • 5. Nootropics market dynamics
  • 6. Nootropics Market Porter's analysis
  • 7. Nootropics: Form (%) analysis, 2025 & 2033
  • 8. Nootropics: Distribution Channel (%) analysis, 2025 & 2033
  • 9. Nootropics: Regional (%) analysis, 2025 & 2033